NICE has this week published its new clinical guideline for depression in adults, following a guideline development process that lasted seven years and resulted in an unprecedented three consultations. The delay follows the persistence of our coalition of stakeholders, that saw BADth join forces with more than forty other mental health organisations to call on NICE to address major methodological flaws that underpinned previous drafts of the guideline.
Never has a draft treatment guideline in the UK received so much scrutiny and detailed attention, and the final version of the guideline has dramatically improved as a consequence. There is now a strong focus on personalised care and a significant emphasis on the importance of service user choice and shared decision-making – all of which were notably absent from previous drafts. These changes should result in significant improvements in care for people with depression as the guideline is implemented.
Our coalition of stakeholders has brought together mental health organisations from across the UK, representing service users; professionals from psychiatry, psychology, social work, counselling and psychotherapy; research methodologists; GPs; pharmacists; nurses; and mental health charities and survivor-led organisations. Together we have argued strongly that the draft guideline wasn’t fit for purpose and that the resulting treatment recommendations would be misleading and impede good care and patient choice. The campaign received support from over 100 MPs and Peers from across all the major parties.
While NICE has not addressed all the key methodological issues we have raised
, the significant efforts made by the Guideline Committee and the substantial additional work that has been carried out in response to our concerns and critique needs to be acknowledged. We hope NICE will learn from this process as future mental health guidelines are developed.
In order to deliver the recommendations in the new guideline, it is important that both the Government and NHS review capacity within the existing mental health workforce and commit to investing in the training and recruitment needed to provide adequate care for people with depression.
It is also important to stress that, despite the progress we have seen in this guideline, important methodological issues remain unaddressed – such as the unvalidated binary categorisation of depression and the failure to meaningfully use real-world clinical outcomes to inform treatment recommendations. Our coalition will continue to work together to encourage NICE to adapt its guideline development process – to ensure the growing number of people seeking mental health care are supported to find the right treatment for them.